SCHEMBL21615028

SCHEMBL21615028

c1ccc(-c2ccc(Nc3cccc4c5ccccc5c5ccccc5c34)cc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.55
GAA P10253 3/20 0.55
KMT2A Q03164 3/20 0.55
KDM4E B2RXH2 2/20 0.55
MAPT P10636 2/20 0.55
TDP1 Q9NUW8 2/20 0.55
GLA P06280 1/20 0.55
RECQL P46063 1/20 0.55
AKR1C3 P42330 3/20 0.53
ALDH1A1 P00352 4/20 0.50
HPGD P15428 2/20 0.50
ATM Q13315 2/20 0.50
ALOX15 P16050 2/20 0.50
TSHR P16473 2/20 0.50
HSD17B10 Q99714 2/20 0.50
TP53 P04637 1/20 0.50
CYP3A4 P08684 1/20 0.50
CDC25B P30305 1/20 0.50
AURKA O14965 1/20 0.44
EPHX2 P34913 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18689337 0.88 MEN1 (0.71) MEN1GAAKMT2AKDM4EMAPT
SCHEMBL30951249 0.88 MEN1 (0.71) MEN1GAAKMT2AKDM4EMAPT
SCHEMBL27379241 0.87 ALDH1A1 (0.51) MEN1GAAKMT2AKDM4EMAPT
SCHEMBL17816623 0.81 AKR1C3 (0.57) MEN1GAAKMT2AKDM4EMAPT
SCHEMBL22523683 0.81 AKR1C3 (0.57) MEN1GAAKMT2AKDM4EMAPT
SCHEMBL1712844 0.81 ALDH1A1 (0.52) MEN1GAAKMT2AKDM4EMAPT
SCHEMBL2794401 0.81 ALDH1A1 (0.78) MEN1GAAKMT2AKDM4EMAPT
SCHEMBL29407531 0.81 ALDH1A1 (0.78) MEN1GAAKMT2AKDM4EMAPT
SCHEMBL10034433 0.81 ALDH1A1 (0.78) MEN1GAAKMT2AKDM4EMAPT
SCHEMBL30556528 0.81 ALDH1A1 (0.78) MEN1GAAKMT2AKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220127251-A1 PROCESS FOR THE PRODUCTION OF ARYLAMINES MERCK PATENT GMBH (DE) 2022-04-28 US disclosed
WO-2020007770-A1 PROCESS FOR THE PRODUCTION OF ARYLAMINES MERCK PATENT GMBH (DE) 2020-01-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220127251-A1 PROCESS FOR THE PRODUCTION OF ARYLAMINES MAOB, TYR, INMT MEN1 2585/4885GAA 277/4885KMT2A 134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.